Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 35 entries
Sorted by: Best Match Show Resources per page
Value in innovative dermatological treatments.

The Journal of dermatological treatment

van de Kerkhof PC.
PMID: 28322080
J Dermatolog Treat. 2017 Mar;28(2):93. doi: 10.1080/09546634.2017.1302560.

No abstract available.

Cite
van de Kerkhof PC. Value in innovative dermatological treatments. J Dermatolog Treat. 2017;28(2):93doi: 10.1080/09546634.2017.1302560.
van de Kerkhof, P. C. (2017). Value in innovative dermatological treatments. The Journal of dermatological treatment, 28(2), 93. https://doi.org/10.1080/09546634.2017.1302560
van de Kerkhof, Peter Cm. "Value in innovative dermatological treatments." The Journal of dermatological treatment vol. 28,2 (2017): 93. doi: https://doi.org/10.1080/09546634.2017.1302560
van de Kerkhof PC. Value in innovative dermatological treatments. J Dermatolog Treat. 2017 Mar;28(2):93. doi: 10.1080/09546634.2017.1302560. PMID: 28322080.
Copy Download .nbib Format: NLM
Branching immune pathways in psoriasis and its significance for disease severity assessment.

The Journal of dermatological treatment

van de Kerkhof PC.
PMID: 30221594
J Dermatolog Treat. 2018 Nov;29(7):641-642. doi: 10.1080/09546634.2018.1515819.

No abstract available.

Cite
van de Kerkhof PC. Branching immune pathways in psoriasis and its significance for disease severity assessment. J Dermatolog Treat. 2018;29(7):641-642doi: 10.1080/09546634.2018.1515819.
van de Kerkhof, P. C. (2018). Branching immune pathways in psoriasis and its significance for disease severity assessment. The Journal of dermatological treatment, 29(7), 641-642. https://doi.org/10.1080/09546634.2018.1515819
van de Kerkhof, Peter Cm. "Branching immune pathways in psoriasis and its significance for disease severity assessment." The Journal of dermatological treatment vol. 29,7 (2018): 641-642. doi: https://doi.org/10.1080/09546634.2018.1515819
van de Kerkhof PC. Branching immune pathways in psoriasis and its significance for disease severity assessment. J Dermatolog Treat. 2018 Nov;29(7):641-642. doi: 10.1080/09546634.2018.1515819. PMID: 30221594.
Copy Download .nbib Format: NLM
From intervention to maintenance treatment to true disease modification in every day treatment of patients with psoriasis.

The Journal of dermatological treatment

van de Kerkhof PC.
PMID: 31023167
J Dermatolog Treat. 2019 May;30(3):207. doi: 10.1080/09546634.2019.1608653.

No abstract available.

Cite
van de Kerkhof PC. From intervention to maintenance treatment to true disease modification in every day treatment of patients with psoriasis. J Dermatolog Treat. 2019;30(3):207doi: 10.1080/09546634.2019.1608653.
van de Kerkhof, P. C. (2019). From intervention to maintenance treatment to true disease modification in every day treatment of patients with psoriasis. The Journal of dermatological treatment, 30(3), 207. https://doi.org/10.1080/09546634.2019.1608653
van de Kerkhof, Peter Cm. "From intervention to maintenance treatment to true disease modification in every day treatment of patients with psoriasis." The Journal of dermatological treatment vol. 30,3 (2019): 207. doi: https://doi.org/10.1080/09546634.2019.1608653
van de Kerkhof PC. From intervention to maintenance treatment to true disease modification in every day treatment of patients with psoriasis. J Dermatolog Treat. 2019 May;30(3):207. doi: 10.1080/09546634.2019.1608653. PMID: 31023167.
Copy Download .nbib Format: NLM
Future perspectives on care for patients with psoriasis. What did we learn during the COVID-19.

The Journal of dermatological treatment

van de Kerkhof PCM.
PMID: 34182877
J Dermatolog Treat. 2021 Aug;32(5):477. doi: 10.1080/09546634.2021.1945655.

No abstract available.

Cite
van de Kerkhof PCM. Future perspectives on care for patients with psoriasis. What did we learn during the COVID-19. J Dermatolog Treat. 2021;32(5):477doi: 10.1080/09546634.2021.1945655.
van de Kerkhof, P. C. M. (2021). Future perspectives on care for patients with psoriasis. What did we learn during the COVID-19. The Journal of dermatological treatment, 32(5), 477. https://doi.org/10.1080/09546634.2021.1945655
van de Kerkhof, Peter C M. "Future perspectives on care for patients with psoriasis. What did we learn during the COVID-19." The Journal of dermatological treatment vol. 32,5 (2021): 477. doi: https://doi.org/10.1080/09546634.2021.1945655
van de Kerkhof PCM. Future perspectives on care for patients with psoriasis. What did we learn during the COVID-19. J Dermatolog Treat. 2021 Aug;32(5):477. doi: 10.1080/09546634.2021.1945655. PMID: 34182877.
Copy Download .nbib Format: NLM
Optimizing shared decision-making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic.

The British journal of dermatology

van Winden MEC, Klösters FM, Hamaker M, Olde Rikkert MG, van de Kerkhof PCM, de Jong EMGJ, Lubeek SFK.
PMID: 34698375
Br J Dermatol. 2021 Oct 26; doi: 10.1111/bjd.20833. Epub 2021 Oct 26.

Balancing the risk for under- and overtreatment in older adults with basal cell carcinoma (BCC) frequently proves challenging.

Cite
van Winden MEC, Klösters FM, Hamaker M, et al. Optimizing shared decision-making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic. Br J Dermatol. 2021;doi: 10.1111/bjd.20833.
van Winden, M. E. C., Klösters, F. M., Hamaker, M., Olde Rikkert, M. G., van de Kerkhof, P. C. M., de Jong, E. M. G. J., & Lubeek, S. F. K. (2021). Optimizing shared decision-making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic. The British journal of dermatology, . https://doi.org/10.1111/bjd.20833
van Winden, M E C, et al. "Optimizing shared decision-making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic." The British journal of dermatology vol. (2021). doi: https://doi.org/10.1111/bjd.20833
van Winden MEC, Klösters FM, Hamaker M, Olde Rikkert MG, van de Kerkhof PCM, de Jong EMGJ, Lubeek SFK. Optimizing shared decision-making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic. Br J Dermatol. 2021 Oct 26; doi: 10.1111/bjd.20833. Epub 2021 Oct 26. PMID: 34698375.
Copy Download .nbib Format: NLM
Our ambition in a changing landscape of psoriasis treatments.

The Journal of dermatological treatment

van de Kerkhof PCM, Feldman SR.
PMID: 31903808
J Dermatolog Treat. 2020 Mar;31(2):105-107. doi: 10.1080/09546634.2020.1712095.

No abstract available.

Cite
van de Kerkhof PCM, Feldman SR. Our ambition in a changing landscape of psoriasis treatments. J Dermatolog Treat. 2020;31(2):105-107doi: 10.1080/09546634.2020.1712095.
van de Kerkhof, P. C. M., & Feldman, S. R. (2020). Our ambition in a changing landscape of psoriasis treatments. The Journal of dermatological treatment, 31(2), 105-107. https://doi.org/10.1080/09546634.2020.1712095
van de Kerkhof, Peter C M, and Feldman, Steven R. "Our ambition in a changing landscape of psoriasis treatments." The Journal of dermatological treatment vol. 31,2 (2020): 105-107. doi: https://doi.org/10.1080/09546634.2020.1712095
van de Kerkhof PCM, Feldman SR. Our ambition in a changing landscape of psoriasis treatments. J Dermatolog Treat. 2020 Mar;31(2):105-107. doi: 10.1080/09546634.2020.1712095. PMID: 31903808.
Copy Download .nbib Format: NLM
The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis.

The British journal of dermatology

van de Kerkhof PCM.
PMID: 34402525
Br J Dermatol. 2021 Nov;185(5):879. doi: 10.1111/bjd.20624. Epub 2021 Aug 17.

No abstract available.

Cite
van de Kerkhof PCM. The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis. Br J Dermatol. 2021;185(5):879doi: 10.1111/bjd.20624.
van de Kerkhof, P. C. M. (2021). The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis. The British journal of dermatology, 185(5), 879. https://doi.org/10.1111/bjd.20624
van de Kerkhof, P C M. "The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis." The British journal of dermatology vol. 185,5 (2021): 879. doi: https://doi.org/10.1111/bjd.20624
van de Kerkhof PCM. The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis. Br J Dermatol. 2021 Nov;185(5):879. doi: 10.1111/bjd.20624. Epub 2021 Aug 17. PMID: 34402525.
Copy Download .nbib Format: NLM
Biologics for psoriasis : maintenance treatment and true disease modification.

The Journal of dermatological treatment

van de Kerkhof PC.
PMID: 28566054
J Dermatolog Treat. 2017 Jun;28(4):281. doi: 10.1080/09546634.2017.1336829.

No abstract available.

Cite
van de Kerkhof PC. Biologics for psoriasis : maintenance treatment and true disease modification. J Dermatolog Treat. 2017;28(4):281doi: 10.1080/09546634.2017.1336829.
van de Kerkhof, P. C. (2017). Biologics for psoriasis : maintenance treatment and true disease modification. The Journal of dermatological treatment, 28(4), 281. https://doi.org/10.1080/09546634.2017.1336829
van de Kerkhof, Peter Cm. "Biologics for psoriasis : maintenance treatment and true disease modification." The Journal of dermatological treatment vol. 28,4 (2017): 281. doi: https://doi.org/10.1080/09546634.2017.1336829
van de Kerkhof PC. Biologics for psoriasis : maintenance treatment and true disease modification. J Dermatolog Treat. 2017 Jun;28(4):281. doi: 10.1080/09546634.2017.1336829. PMID: 28566054.
Copy Download .nbib Format: NLM
Tacalcitol : A Viewpoint by P.C.M. van de Kerkhof.

Drugs

van de Kerkhof PC.
PMID: 27519255
Drugs. 1997 Aug;54(2):272. doi: 10.2165/00003495-199754020-00006.

No abstract available.

Cite
van de Kerkhof PC. Tacalcitol : A Viewpoint by P.C.M. van de Kerkhof. Drugs. 1997;54(2):272doi: 10.2165/00003495-199754020-00006.
van de Kerkhof, P. C. (1997). Tacalcitol : A Viewpoint by P.C.M. van de Kerkhof. Drugs, 54(2), 272. https://doi.org/10.2165/00003495-199754020-00006
van de Kerkhof, P C. "Tacalcitol : A Viewpoint by P.C.M. van de Kerkhof." Drugs vol. 54,2 (1997): 272. doi: https://doi.org/10.2165/00003495-199754020-00006
van de Kerkhof PC. Tacalcitol : A Viewpoint by P.C.M. van de Kerkhof. Drugs. 1997 Aug;54(2):272. doi: 10.2165/00003495-199754020-00006. PMID: 27519255.
Copy Download .nbib Format: NLM
Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic.

The British journal of dermatology

van Winden MEC, Klösters FM, Hamaker M, Olde Rikkert MG, van de Kerkhof PCM, de Jong EMGJ, Lubeek SFK.
PMID: 34698375
Br J Dermatol. 2021 Oct 26; doi: 10.1111/bjd.20833. Epub 2021 Oct 26.

No abstract available.

Cite
van Winden MEC, Klösters FM, Hamaker M, et al. Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic. Br J Dermatol. 2021;doi: 10.1111/bjd.20833.
van Winden, M. E. C., Klösters, F. M., Hamaker, M., Olde Rikkert, M. G., van de Kerkhof, P. C. M., de Jong, E. M. G. J., & Lubeek, S. F. K. (2021). Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic. The British journal of dermatology, . https://doi.org/10.1111/bjd.20833
van Winden, M E C, et al. "Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic." The British journal of dermatology vol. (2021). doi: https://doi.org/10.1111/bjd.20833
van Winden MEC, Klösters FM, Hamaker M, Olde Rikkert MG, van de Kerkhof PCM, de Jong EMGJ, Lubeek SFK. Optimizing shared decision making in older adults with basal cell carcinoma: experiences from a specialized outpatient clinic. Br J Dermatol. 2021 Oct 26; doi: 10.1111/bjd.20833. Epub 2021 Oct 26. PMID: 34698375.
Copy Download .nbib Format: NLM
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.

Dermatology and therapy

Lebwohl M, Langley RG, Paul C, Puíg L, Reich K, van de Kerkhof P, Wu HL, Richter S, Jardon S, Gisondi P.
PMID: 34704231
Dermatol Ther (Heidelb). 2021 Oct 25; doi: 10.1007/s13555-021-00635-4. Epub 2021 Oct 25.

INTRODUCTION: Since the 2012 Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey, several systemic treatments for psoriasis (PsO) and/or psoriatic arthritis (PsA) have been approved. The population-based UPLIFT survey was conducted to understand how perceptions of treatment-related outcomes...

Cite
Lebwohl M, Langley RG, Paul C, et al. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey. Dermatol Ther (Heidelb). 2021;doi: 10.1007/s13555-021-00635-4.
Lebwohl, M., Langley, R. G., Paul, C., Puíg, L., Reich, K., van de Kerkhof, P., Wu, H. L., Richter, S., Jardon, S., & Gisondi, P. (2021). Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey. Dermatology and therapy, . https://doi.org/10.1007/s13555-021-00635-4
Lebwohl, Mark, et al. "Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey." Dermatology and therapy vol. (2021). doi: https://doi.org/10.1007/s13555-021-00635-4
Lebwohl M, Langley RG, Paul C, Puíg L, Reich K, van de Kerkhof P, Wu HL, Richter S, Jardon S, Gisondi P. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey. Dermatol Ther (Heidelb). 2021 Oct 25; doi: 10.1007/s13555-021-00635-4. Epub 2021 Oct 25. PMID: 34704231; PMCID: PMC8547901.
Copy Download .nbib Format: NLM
Sustainable Healthcare in Dermatology: From management of diseases to empathy for well-being.

The Journal of dermatological treatment

van de Kerkhof PC.
PMID: 27934553
J Dermatolog Treat. 2016 Nov;27(6):485-487. doi: 10.1080/09546634.2016.1268295.

No abstract available.

Cite
van de Kerkhof PC. Sustainable Healthcare in Dermatology: From management of diseases to empathy for well-being. J Dermatolog Treat. 2016;27(6):485-487doi: 10.1080/09546634.2016.1268295.
van de Kerkhof, P. C. (2016). Sustainable Healthcare in Dermatology: From management of diseases to empathy for well-being. The Journal of dermatological treatment, 27(6), 485-487. https://doi.org/10.1080/09546634.2016.1268295
van de Kerkhof, Peter Cm. "Sustainable Healthcare in Dermatology: From management of diseases to empathy for well-being." The Journal of dermatological treatment vol. 27,6 (2016): 485-487. doi: https://doi.org/10.1080/09546634.2016.1268295
van de Kerkhof PC. Sustainable Healthcare in Dermatology: From management of diseases to empathy for well-being. J Dermatolog Treat. 2016 Nov;27(6):485-487. doi: 10.1080/09546634.2016.1268295. PMID: 27934553.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 35 entries